Breast Imaging Market

Breast Imaging Market

Market Synopsis

The global Breast Imaging Market is valued at USD 5.68 Billion in 2024 and is projected to reach a value of USD 15.86 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 9.85% between 2025 and 2035. Breast imaging is a subspecialty of diagnostic radiology that uses ionizing or non-ionizing radiation to detect tumors in the breast. This technique allows clinicians to make an early diagnosis before the actual symptoms are present. The development of hybrid imaging systems and the extensive research in the development of hybrid imaging systems provide the market with significant growth opportunities over the forecast period. The global incidence of breast cancer is rising, and the burden of women with a backlog of cancer screening appointments due to COVID-19, has underlined the importance of women’s health and early detection of cancer. Breast cancer is expected to become the most diagnosed cancer, surpassing lung cancer as the most prevalent. The heightened expectations for government screening programs are a result of the worlds steady increase in breast cancer incidence. To reduce breast cancer mortality, screening programs alone are not enough, accuracy in breast cancer detection must be improved, while false positives and missed lesions must also be reduced. These factors are expected to be at the forefront of breast imaging for both screening and diagnosis. The breast imaging market is fueled by stronger awareness of the benefits of breast cancer screening programs, as well as the need to improve breast cancer detection accuracy. This, along with a patient-centric approach to screening and technological advances to improve patient comfort, are among the methods being employed to improve participation in screening programs, which in turn has boosted the adoption of mammography X-ray equipment.

Market Segmentation:

The global breast imaging market is classified into type of imaging technique, end user, and region. On the basis of type of imaging technique, the target market is bifurcated as mammography, breast ultrasound, breast MRI, image-guided breast biopsy and other imaging techniques. Based on end user, the target market is segmented as hospitals, diagnostic centers, and others.

The mammography segment holds the largest market share during the forecast period

The mammography segment in ionizing technology of the global breast imaging market is growing because of many initiatives taken for the early detection of breast cancer. The United States Preventive Services Task Force, for example, has developed guidelines for mammography screening. Moreover, the growing geriatric population and the rising incidence of breast cancer globally will push mammography demand up. According to the American Cancer Society, in the United States, there were 8,130 Ductal carcinomas in situ ( DCIS ) and 37,150 new cases of invasive breast cancer among women aged 40 to 49 years in 2019. The 3D breast tomosynthesis segment is expected to grow at the fastest CAGR during the forecast period because of the rising incidence of breast cancer. This growth is attributable mainly to this technology’s sharp image outputs and reduced recall rates. 3D breast tomosynthesis also overcomes the limitations of standard mammography by allowing detection of all types of lesions.

Hospitals segment accounts for the largest market share during the forecast period

Hospitals hold the largest share of the overall breast imaging market in 2020, with a combination of increased spending on healthcare infrastructure, higher purchasing power, more equipped operating and diagnostic rooms, as well as better health coverage for hospital-based healthcare services.{{segment_3_graph}}

Asia Pacific region dominated the Breast Imaging Market during the forecast period

North America holds largest share of the global breast imaging market in 2017. This is mainly due to rise in prevalence of breast cancer, rising healthcare expenditure, and use of breast imaging as screening. However, Asia Pacific is expected to be the fastest growing region and the segment would grow at a high CAGR during the forecast period. This can be credited to increase in incidence of cancer in this region, as well as increased prevalence of early detection and diagnosis of breast cancer. The increase in the number of healthcare providers and radiology centers is expected to provide impetus to the target market. Additionally, increase in demand for advanced imaging technology including PET-CT and MRI are also driving the global breast imaging market growth in the region. Another key factor fueling the markets growth is frequency of breast screening programs to raise awareness about the importance of early diagnosis in the region.

Competitive Landscape-

Some of the major key players in the breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Inc. (Japan), Siemens Healthineers (Germany), Aurora Healthcare US Corp. (US), Fujifilm Holdings Corporation (Japan), Allengers (India), Dilon Technologies, Inc. (US), Delphinus Medical Technologies, Inc. (US), Planmed Oy (Finland), Micrima Limited (UK), SuperSonic Imagine (France), CMR Naviscan Corporation (US), and Carestream Health (US).

Breast Imaging Market is segmented as follows:

Breast Imaging Market is tabulated as follows: